This volume gives a state-of-the-art account of new diagnostic approaches tocerebrovascular diseases and the rationale for the use of thrombolytic agents in acute stroke Particular attention is paid to the latest developments of thrombolytic drugs. The result of all major safety and efficiency trials (recombinant tissue-type plasminogen activator)